| abstract |
The present invention provides a benzo[d]thiazole derivative or a pharmaceutically acceptable salt thereof, a method for producing the same, and a pharmaceutical composition including the same. The benzo[d]thiazole derivative or the pharmaceutically acceptable salt thereof selectively inhibits a protein-protein interaction of KRS and laminin receptor (LR), thereby being able to inhibit the movement of cancer cells. Accordingly, the benzo[d]thiazole derivative or the pharmaceutically acceptable salt thereof can be usefully applied to the prevention or treatment of cancer cell metastasis-mediated diseases. |